All articles by Gujjarlapudi Satish
Gujjarlapudi Satish
TransEnterix acquires Israeli medical technology company MST
US-based TransEnterix has purchased Israel-based medical technology company MST Medical Surgery Technologies (MST) in a cash and stock transaction.
Foundation Medicine launches new liquid biopsy test in US
Cancer diagnostics firm Foundation Medicine, a member of the Roche Group, has introduced its new liquid biopsy test for solid tumours for commercial use in the US.
Study finds outbreak of rare infection among contact lens users
Researchers from UCL and Moorfields Eye Hospital have discovered an outbreak of a rare but preventable eye infection, Acanthamoeba keratitis, which can cause blindness in contact lens wearers.
Stryker agrees to buy Invuity for $190m
Stryker has agreed to acquire medical technology company Invuity in a cash deal valued at approximately $190m.
FDA clears Masimo’s RAS-45 sensor for neonatal patient use
Medical technology company Masimo has received FDA clearance for its Rainbow Acoustic Monitoring (RAM) RAS-45 acoustic respiration sensor for infant and neonatal use.
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Blood test developed to detect secondary heart attack risk
Researchers from the Australia-based Baker Heart and Diabetes Institute have developed a new blood test that can help to quickly and easily detect the risk of a secondary heart attack.
Johnson & Johnson to compensate faulty hip implant patients in India
Johnson & Johnson (J&J) has agreed to work with the Indian government to offer compensation to patients who were affected by faulty hip implants.
General Electric and DARPA partner for diabetes research project
General Electric (GE) has collaborated with the Defense Advanced Research Projects Agency (DARPA) on a $2.9m research project to develop non-drug treatments for diabetes.
Boston Scientific to buy Augmenix for $500m
Boston Scientific has reached an agreement to buy Augmenix for $500m in upfront cash and up to an additional $100m in sales-based milestones.
Philips releases new TissueMark computational pathology software
Health technology major Royal Philips has introduced an updated version of its TissueMark computational pathology solution software at Euskalduna Conference Centre in Bilbao, Spain.